Search

Your search keyword '"Mark E. Cooper"' showing total 947 results

Search Constraints

Start Over You searched for: Author "Mark E. Cooper" Remove constraint Author: "Mark E. Cooper" Topic medicine Remove constraint Topic: medicine
947 results on '"Mark E. Cooper"'

Search Results

1. Inhibition of pancreatic EZH2 restores progenitor insulin in T1D donor

2. Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes

3. Solidified glomerulosclerosis, identified using single glomerular proteomics, predicts end-stage renal disease in Chinese patients with type 2 diabetes

4. DNA methylation status correlates with adult β-cell regeneration capacity

5. Amylin in the Periphery

6. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis

7. Association between serum uric acid and renal outcome in patients with biopsy-confirmed diabetic nephropathy

8. Advances in clinical research in chronic kidney disease

9. Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function

10. Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A4 Mimetics (QNX-sLXms)

11. Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950

12. Key profibrotic and pro-inflammatory pathways in the pathogenesis of diabetic kidney disease

13. Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy

14. The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial

15. Synergy of the Polymyxin-Chloramphenicol Combination against New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae Is Predominately Driven by Chloramphenicol

16. Early-onset of type 2 diabetes mellitus is a risk factor for diabetic nephropathy progression: a biopsy-based study

17. Apoptotic Ablation of Platelets Reduces Atherosclerosis in Mice With Diabetes

18. The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65 years: Results from the <scp>ADVANCE</scp> trial

19. Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus

20. Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial

21. A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville score

22. Contemporary Management of Heart Failure in Patients With Diabetes

23. Antitubercular and Antiparasitic 2-Nitroimidazopyrazinones with Improved Potency and Solubility

24. Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis

25. Alternative kidney filtration markers and the risk of major macrovascular and microvascular events, and <scp>all‐cause</scp> mortality in individuals with type 2 diabetes in the <scp>ADVANCE</scp> trial

26. Sex‐specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The <scp>ADVANCE‐ON</scp> study

27. Evaluating the efficacy and safety of GKT137831 in adults with type 1 diabetes and persistently elevated urinary albumin excretion: a statistical analysis plan

28. Discovery of Cephalosporin-3′-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against Pseudomonas aeruginosa Clinical Cystic Fibrosis Isolates and Efficacy in a Murine Respiratory Infection Model

29. Nox (NADPH Oxidase) 1, Nox4, and Nox5 Promote Vascular Permeability and Neovascularization in Retinopathy

30. Diabetic Retinopathy, Classified Using the Lesion-Aware Deep Learning System, Predicts Diabetic End-Stage Renal Disease in Chinese Patients

31. Renal protection: What have we learnt from ADVANCE about kidney disease in type 2 diabetes?

32. Flow-cytometry detection of fluorescent magnetic nanoparticle clusters increases sensitivity of dengue immunoassay

33. Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A1c in the ADVANCE Trial

34. Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo‐controlled CARMELINA® trial

35. Light‐Activated Rhenium Complexes with Dual Mode of Action against Bacteria

36. Metal complexes as a promising source for new antibiotics

37. Delineating a role for the mitochondrial permeability transition pore in diabetic kidney disease by targeting cyclophilin D

38. Targeting Methylglyoxal in Diabetic Kidney Disease Using the Mitochondria-Targeted Compound MitoGamide

39. Role of cFOS in mechanosensitive transcriptional regulation in diabetes associated atherosclerosis

40. Effect of Preemptive Intervention on Developmental Outcomes Among Infants Showing Early Signs of Autism

41. Risk Factors for Gut Dysbiosis in Early Life

42. 187Racial discrimination, life stress and allostatic load in Aboriginal and Torres Strait Islander adults

43. Long-term laryngotracheal complications following cardiac surgery

44. Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial

45. Unresolved grief in parents of children with CF: A pilot randomised controlled trial on the use and delivery sequence of disease-related education and psychotherapeutic support

46. Retinal Differential Light Sensitivity Variation Across the Macula in Healthy Subjects: Importance of Cone Separation and Loci Eccentricity

47. Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility

48. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins

49. Pre-emptive intervention versus treatment as usual for infants showing early behavioural risk signs of autism spectrum disorder: a single-blind, randomised controlled trial

50. Significant Associations Between Sun Exposure and Adiposity Were Not Observed in Breast and Prostate Cancer Patients in a Cross‐sectional Analysis

Catalog

Books, media, physical & digital resources